8 completed, 2 recruiting, 2 withdrawn, 1 active not recruiting. 5 Not applicable, 5 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 2, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 5 | Completed 3, Recruiting 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow Invasive Ductal Breast Carcinoma: new trials by email Literature Review of Invasive Ductal Breast Carcinoma trials Research Report on Invasive Ductal Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue Palliative radiotherapy - Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 26 | 2023-07-24 | 2026-09-02 |
| Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer Degarelix injection(s) - Invasive Ductal Breast Carcinoma | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 8 | 2019-11-28 | 2026-03-31 |
| Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer Accelerated Partial Breast Irradiation - Invasive Ductal Breast Carcinoma, Invasive Ductal Carcinoma, Breast | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 280 | 2019-08-30 | 2026-09-21 |
| Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer Radiomic, pathomic, and clinical markers - Breast Cancer, Invasive Ductal Breast Carcinoma | Unknown | Sunnybrook Health Sciences Centre | 800 | 2018-08-30 | 2019-07-16 | |
| Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Talimogene laherparepvec, Paclitaxel - Breast Cancer, Ductal Carcinoma | Phase 1 / Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 50 | 2017-05-02 | 2026-03-10 |
| Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer accelerated partial breast irradiation, intensity-modulated radiation therapy, image-guided radiation therapy - Estrogen Receptor-positive Breast Cancer, Invasive Ductal Breast Carcinoma | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 22 | 2016-04-29 | 2025-09-22 |
| Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 Carboplatin, Abraxane, MPDL3280A - Invasive Ductal Breast Carcinoma | Phase 3 | Completed | Fondazione Michelangelo | 278 | 2016-04-01 | 2024-03-06 |
| Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery fulvestrant, anastrozole - Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 1473 | 2014-02-27 | 2026-06-05 |
| BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer PI3K inhibitor BYL719, letrozole, laboratory biomarker analysis - Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 1 | Completed | Vanderbilt-Ingram Cancer Center | 46 | 2013-04-01 | 2026-08-19 |
| Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy Behavioral dietary intervention, Therapeutic conventional surgery, Radiation therapy - Ductal Breast Carcinoma in Situ, Invasive Ductal Breast Carcinoma | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 38 | 2013-03-08 | 2025-06-06 |
| Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid zoledronic acid, laboratory biomarker analysis, therapeutic conventional surgery - Estrogen Receptor-positive Breast Cancer, Invasive Ductal Breast Carcinoma | Not applicable | Terminated | City of Hope Medical Center | 9 | 2012-09-14 | 2020-05-08 |
| Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Cancer magnetic resonance thermal imaging, laser interstitial thermal therapy - Ductal Breast Carcinoma in Situ, Invasive Ductal Breast Carcinoma | Not applicable | Withdrawn | University of Chicago | 2012-08-01 | 2014-10-15 | |
| Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer External beam radiation therapy - Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma | Phase 2 | Completed | Rutgers, The State University of New Jersey | 69 | 2010-12-21 | 2023-04-20 |
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer external beam radiation therapy, questionnaire administration, therapeutic conventional surgery - Ductal Breast Carcinoma in Situ, Estrogen Receptor-negative Breast Cancer | Phase 2 | Withdrawn | Case Comprehensive Cancer Center | 2010-02-01 | 2011-12-08 | |
| Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer hyperfractionated radiation therapy, laboratory biomarker analysis, stereotactic radiosurgery - Central Nervous System Metastases, Invasive Ductal Breast Carcinoma | Completed | University of Chicago | 4 | 2009-06-15 | 2024-07-31 |
Carcinoma, Ductal, Breast (15) · Breast Neoplasms (12) · Carcinoma, Lobular (7) · Carcinoma, Intraductal, Noninfiltrating (4) · Breast Carcinoma In Situ (2) · Breast Neoplasms, Male (2) · Triple Negative Breast Neoplasms (2) · Brain Neoplasms (1) · Carcinoma, Ductal (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Gastrointestinal Neoplasms (1) · Inflammatory Breast Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1)
Adenocarcinoma (15) · Breast Diseases (15) · Carcinoma (15) · Neoplasms (15) · Neoplasms by Histologic Type (15) · Neoplasms by Site (15) · Neoplasms, Ductal, Lobular, and Medullary (15) · Neoplasms, Glandular and Epithelial (15) · Skin Diseases (15) · Skin and Connective Tissue Diseases (15) · Carcinoma, Ductal (14) · Carcinoma in Situ (5) · Breast Carcinoma In Situ (3) · Breast Neoplasms (3) · Brain Diseases (1)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Alpelisib (1) · Anastrozole (1) · Carboplatin (1) · Counseling (1) · Fulvestrant (1) · Letrozole (1) · Paclitaxel (1) · Radiation (1) · Radiomics (1) · Radiosurgery (1) · Radiotherapy (1) · Radiotherapy, Image-Guided (1) · Radiotherapy, Intensity-Modulated (1)
Memorial Sloan Kettering Cancer Center (2) · University of Chicago (2) · Alliance for Clinical Trials in Oncology (1) · Assistance Publique - Hôpitaux de Paris (1) · Case Comprehensive Cancer Center (1) · City of Hope Medical Center (1) · Fondazione Michelangelo (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Ohio State University Comprehensive Cancer Center (1) · Rutgers, The State University of New Jersey (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Sunnybrook Health Sciences Centre (1) · Vanderbilt-Ingram Cancer Center (1)
United States (12) · Austria (1) · Canada (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Puerto Rico (1) · Russia (1) · Spain (1) · Taiwan (1)
Atif J Khan, MD (1) · Atif Khan, MD (1) · Bruce Haffty, MD (1) · Cynthia Ma, MD, PhD (1) · Fang-I Lu, MD, FRCPC (1) · Hatem Soliman, M.D. (1) · Hiroyuki Abe (1) · Joanne Mortimer (1) · Kasia Jerzak, M.Sc., MD (1) · Laura Kennedy (1) · Luca Gianni, MD (1) · Nicole Simone, MD (1) · Sasha Beyer, MD (1) · Steven Chmura (1)
PMID 28045625, PMID 32450725, PMID 35182721, PMID 36759673, PMID 38236590
2014 (1), 2018 (1), P30CA056036 (1), P30CA072720 (1), U10CA031946 (1)